Mycoplasma fermentans glycolipid-antigen as a pathogen of rheumatoid arthritis
Creators
- 1. Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-ku, Kawaramachi-Hirokoji Kamigyo-ku, Kyoto-shi, Kyoto 602-0841 (Japan)
- 2. Laboratory for Electron Microscopy, Tokyo Medical and Dental University, 5-45, Yushima 1-chome, Bunkyo-ku, Tokyo 113-8519 (Japan)
- 3. Arthiritis and Rheumatism Branch, Department of Internal Medicine, Hyogo Medical College of Medicine, 1-1, Nishinomiya, Mukogawa-cho, Hyogo 663-8501 (Japan)
- 4. Department of Orthopedics, Kyoto Prefectural University of Medicine, 465 Kajii-ku, Kawaramachi-Hirokoji Kamigyo-ku, Kyoto, Kyoto 602-0841 (Japan)
- 5. Department of Veterinary Medicine, Faculty of Agriculture, Iwate University, 3-18-8, Ueda, Morioka, Iwate 020-8550 (Japan)
- 6. Department of Rheumatology and Internal medicine, OUR LADY OF SNOW Medical Juridical Corporation ST. MARY'S HOSPITAL, 422 Tsubukuhon-machi Kurume City, Fukuoka 830-8543 (Japan)
- 7. Department of Research and Developments, M Bio Technology Inc., Koto-ku, TIME 24 Building 10F, Aomi 2-45, Koto-ku, Tokyo 135-8073 (Japan)
Description
Mycoplasma fermentans has been suspected as one of the causative pathogenic microorganisms of rheumatoid arthritis (RA) however, the pathogenic mechanism is still unclear. We, previously, reported that glycolipid-antigens (GGPL-I and III) are the major antigens of M. fermentans. Monoclonal antibody against the GGPL-III could detect the existence of the GGPL-III antigens in synovial tissues from RA patients. GGPL-III antigens were detected in 38.1% (32/84) of RA patient's tissues, but not in osteoarthritis (OA) and normal synovial tissues. Immunoelectron microscopy revealed that a part of GGPL-III antigens are located at endoplasmic reticulum. GGPL-III significantly induced TNF-α and IL-6 production from peripheral blood mononulear cells, and also proliferation of synovial fibroblasts. Further study is necessary to prove that M. fermentans is a causative microorganism of RA; however, the new mechanisms of disease pathogenesis provides hope for the development of effective and safe immunotherapeutic strategies based on the lipid-antigen, GGPL-III, in the near future
Availability note (English)
Available from http://dx.doi.org/10.1016/j.bbrc.2008.02.079Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2008.02.079;
- PII
- S0006-291X(08)00312-4;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 369
- Journal Issue
- 2
- Journal Page Range
- p. 561-566
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 40023564
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ANTIGENS; BLOOD; DISEASES; ENDOPLASMIC RETICULUM; FIBROBLASTS; LIPIDS; MICROSCOPY; MONOCLONAL ANTIBODIES; MYCOPLASMA; PATHOGENESIS; PATHOGENS; PATIENTS; RHEUMATIC DISEASES
- Descriptors DEC
- ANIMAL CELLS; ANTIBODIES; BIOLOGICAL MATERIALS; BODY FLUIDS; CELL CONSTITUENTS; CONNECTIVE TISSUE CELLS; MATERIALS; MICROORGANISMS; ORGANIC COMPOUNDS; SOMATIC CELLS
Optional Information
- Copyright
- Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.